Getinge Showcases Global Scale and Life-Saving Focus in 2025 Annual Report

Getinge ( ($SE:GETI.B) ) has shared an announcement.

Getinge’s 2025 annual report highlights a business generating SEK 35 billion in net sales, supported by a workforce of roughly 12,000 employees and a customer base of about 30,000 across more than 135 countries. The release underscores the company’s long-standing focus on life‑saving and quality‑of‑life‑improving medical innovations, positioning it as a significant player in global healthcare delivery.

By emphasizing both scale and mission, the report signals Getinge’s ongoing commitment to providing critical technologies at key points of care worldwide. This sustained focus on innovation and broad international reach is central to its strategy to remain competitive in the medtech industry and to support healthcare providers in meeting rising patient needs.

The most recent analyst rating on ($SE:GETI.B) stock is a Hold with a SEK201.00 price target. To see the full list of analyst forecasts on Getinge stock, see the SE:GETI.B Stock Forecast page.

More about Getinge

Getinge is a global medical technology company serving around 30,000 customers in more than 135 countries with solutions designed to improve and save lives. With about 12,000 employees and SEK 35 billion in net sales in 2025, it focuses on innovations that enhance quality of life across the healthcare sector.

Average Trading Volume: 705,258

Technical Sentiment Signal: Sell

Current Market Cap: SEK50.33B

See more insights into GETI.B stock on TipRanks’ Stock Analysis page.